Zobrazeno 1 - 10
of 1 936
pro vyhledávání: '"A Arkwright"'
Autor:
RM Gunner, RP Wilson, MD Holton, R Scott, A Arkwright, A Fahlman, M Ulrich, P Hopkins, C Duarte, C Eizaguirre
Publikováno v:
Endangered Species Research, Vol 45, Pp 1-12 (2021)
Understanding the behavioural ecology of endangered taxa can inform conservation strategies. The activity budgets of the loggerhead turtle Caretta caretta are still poorly understood because many tracking methods show only horizontal displacement and
Externí odkaz:
https://doaj.org/article/09d617073ea4471d961ae0d463c03e86
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 584-596 (2024)
Introduction Rotavirus is a leading cause of severe diarrheal disease and death in children under five years of age worldwide. Vaccination is one of the most important public health interventions to reduce this significant burden.Areas covered This l
Externí odkaz:
https://doaj.org/article/4ef3cbb2f8124cd89202124fdd3c093c
Autor:
Deepika Roshith, Christopher Rawlingson, Timothy H. Clayton, Chitra Sethuraman, Peter D. Arkwright
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 4, Pp 1244-1247 (2024)
Abstract Neutrophilic dermatoses are autoinflammatory disorders characterised by sterile cutaneous inflammatory neutrophilic infiltrates. This group of diseases is rare in infants and children, where sepsis is the diagnosis of exclusion. This report
Externí odkaz:
https://doaj.org/article/d2951911ea0041eca8d5f8fc437cb873
Autor:
Paller, Amy S., Silverberg, Jonathan I., Simpson, Eric L., Cork, Michael J., Arkwright, Peter D., Chen, Zhen, Bansal, Ashish, Prescilla, Randy, Wang, Zhixiao, Marco, Ainara R.
Publikováno v:
In Journal of the American Academy of Dermatology January 2025 92(1):116-126
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 226-242 (2023)
Introduction Despite children aged 6–35 months developing more severe influenza infections, not all countries include influenza vaccines in their national immunization programs. Areas covered This literature review examines the efficacy, immunogeni
Externí odkaz:
https://doaj.org/article/1d2501672f8a40429307bcf3c956a3f8
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 104-117 (2023)
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b. Areas Covered To e
Externí odkaz:
https://doaj.org/article/dfba5fd16e6f4a79b95554600d27f68d
Autor:
Vallée, Tanja C., Glasmacher, Jannik S., Buchner, Hannes, Arkwright, Peter D., Behrends, Uta, Bondarenko, Anastasia, Browning, Michael J., Buchbinder, David, Cattoni, Alessandro, Chernyshova, Liudmyla, Ciznar, Peter, Cole, Theresa, Czogała, Wojciech, Dueckers, Gregor, Edgar, John David M., Erbey, Fatih, Fasth, Anders, Ferrua, Francesca, Formankova, Renata, Gambineri, Eleonora, Gennery, Andrew R., Goldman, Frederick D., Gonzalez-Granado, Luis I., Heilmann, Carsten, Heiskanen-Kosma, Tarja, Juntti, Hanna, Kainulainen, Leena, Kanegane, Hirokazu, Karaca, Neslihan E., Kilic, Sara S., Klein, Christoph, Kołtan, Sylwia, Kondratenko, Irina, Meyts, Isabelle, Nasrullayeva, Gulnara M., Notarangelo, Lucia D., Pasic, Srdjan, Pellier, Isabelle, Pignata, Claudio, Misbah, Siraj, Schulz, Ansgar, Segundo, Gesmar R., Shcherbina, Anna, Slatter, Mary, Sokolic, Robert, Soler-Palacin, Pere, Stepensky, Polina, van Montfrans, Joris M., Ryhänen, Samppa, Wolska-Kuśnierz, Beata, Ziegler, John B., Zhao, Xiaodong, Aiuti, Alessandro, Ochs, Hans D., Albert, Michael H.
Publikováno v:
In Blood 13 June 2024 143(24):2504-2516
Autor:
Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2697-2719 (2023)
Abstract Background For children aged 6–11 years with uncontrolled severe atopic dermatitis (AD), 16 weeks of treatment with dupilumab resulted in substantial clinical benefit compared with placebo with an acceptable safety profile. However, longer
Externí odkaz:
https://doaj.org/article/4dab87121bb04ebfa5a3e58c15eea599
Autor:
Elaine C. Siegfried, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Lara Wine Lee, Zhen Chen, Randy Prescilla, Ashish Bansal, Noah A. Levit, Ainara Rodríguez Marco
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 9, Pp 1987-2000 (2023)
Abstract Introduction Atopic dermatitis (AD) is heterogeneous in distribution pattern and clinical features. This analysis assessed the effect of dupilumab on the extent and severity of AD across various signs (erythema, edema/papulation, excoriation
Externí odkaz:
https://doaj.org/article/7f9dd1149078422ab5b7d8705d2ca580
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.